Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGames Workshop Regulatory News (GAW)

Share Price Information for Games Workshop (GAW)

Share Price is delayed by 15 minutes
Get Live Data
18,980.00    -120.00 (-0.63%)
Bid:
18,980.00
Ask:
19,010.00
Spread: 30.00 (0.158%)
Market Cap: £6.27b
GAW Live PriceLast checked at - London Stock Exchange

Intraday Games Workshop Share Chart

Director Declaration

22 Nov 2021 07:00

RNS Number : 0459T
Games Workshop Group PLC
22 November 2021
 

22 November 2021

Games Workshop Group PLC

("Games Workshop" or the "Company")

Disclosure of New Directorship

 

Games Workshop announces that Kate Marsh, an independent non-executive director of the Company, has become an independent non-executive director of Devolver Digital Inc. as listed on the Alternative Investment Market of the London Stock Exchange.

For further information please contact:

Ross Matthews

Group Company Secretary

investorrelations@gwplc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RDNBBBBTMTTTTTB
Date   Source Headline
1st Mar 20177:00 amRNSTotal Voting Rights
17th Feb 20171:30 pmRNSHolding(s) in Company
1st Feb 20177:00 amRNSTotal Voting Rights
30th Jan 20178:31 amRNSHolding(s) in Company
17th Jan 20172:10 pmRNSTrading statement and dividend
10th Jan 20177:00 amRNSHalf-year Report
3rd Jan 20177:00 amRNSTotal Voting Rights
13th Dec 20169:51 amRNSHolding(s) in Company
5th Dec 20165:20 pmRNSDirector/PDMR Shareholding
5th Dec 201611:24 amRNSHolding(s) in Company
1st Dec 201611:04 amRNSTrading Statement
1st Dec 20167:00 amRNSTotal Voting Rights
22nd Nov 20162:12 pmRNSHolding(s) in Company
14th Nov 201610:49 amRNSHolding(s) in Company
2nd Nov 20169:11 amRNSDirector/PDMR Shareholding
1st Nov 201611:21 amRNSTotal Voting Rights
17th Oct 20161:33 pmRNSDividend Declaration
6th Oct 20163:08 pmRNSTrading Statement
14th Sep 20164:29 pmRNSHolding(s) in Company
14th Sep 20164:28 pmRNSResult of AGM
1st Sep 20167:00 amRNSBlock listing Interim Review
16th Aug 20168:50 amRNSDirector/PDMR Shareholding
1st Aug 20167:00 amRNSHolding(s) in Company
26th Jul 201611:32 amRNSAnnual Financial Report
26th Jul 20167:00 amRNSAnnual Financial Report
28th Jun 201612:07 pmRNSSecond Price Monitoring Extn
28th Jun 201612:02 pmRNSPrice Monitoring Extension
21st Jun 20163:08 pmRNSHolding(s) in Company
14th Jun 20169:51 amRNSHolding(s) in Company
10th Jun 20169:12 amRNSHolding(s) in Company
6th Jun 20164:08 pmRNSTrading update
6th Jun 20169:20 amRNSDirector/PDMR Shareholding
3rd May 20167:00 amRNSTotal Voting Rights
20th Apr 201612:43 pmRNSDividend Declaration
1st Apr 20167:00 amRNSTotal Voting Rights
1st Feb 20167:00 amRNSTotal Voting Rights
8th Jan 20167:00 amRNSHalf-yearly report and trading update
4th Jan 20167:00 amRNSTotal Voting Rights
7th Dec 20157:00 amRNSTrading update
1st Dec 20157:00 amRNSTotal Voting Rights
27th Nov 20153:48 pmRNSHolding(s) in Company
2nd Nov 201512:26 pmRNSHolding(s) in Company
2nd Nov 20157:00 amRNSTotal Voting Rights
1st Oct 20157:00 amRNSTotal Voting Rights
22nd Sep 20151:13 pmRNSDirector/PDMR Shareholding
16th Sep 20154:25 pmRNSDirector/PDMR Shareholding
16th Sep 20151:23 pmRNSResult of Annual General Meeting
1st Sep 20159:00 amRNSBlocklisting Interim Review
1st Sep 20157:03 amRNSTotal Voting Rights
13th Aug 20151:11 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.